• Funded +2,000 research programs
  • Raised $745+ million
  • Founded in 1993
← Back to projects list

Precision Imaging & Detection

Fund research into new imaging technology that can lead to earlier detection and prolonged survival.

  • $40,110 pledged of $50K (80%)
  • 389 backers
  • 56 days to go

Researchers

  • Rana McKay, MD
    University of California, San Diego
  • Michael Hahn, MD, PhD
    University of California, San Diego
  • David Karow, MD, PhD
    University of California, San Diego

Development of a More Sensitive Imaging Method for Improved Detection, Characterization and Therapy Response of Metastatic Prostate Cancer

Improved and earlier detection of metastases can prolong the survival of patients with potentially lethal disease.

Restriction Spectrum Imaging-Magnetic Response Imaging (RSI-MRI), is a radiation-free method that can detect tumors based on tissue characteristics.

Prostate Cancer Foundation-funded researchers are optimizing RSI-MRI for more sensitive detection of metastatic prostate cancer and for assessment of responses to treatment.

This will lead to improved and earlier detection of metastases, and enhance the ability to treat and prolong the survival of patients with potentially lethal disease.

  • $40,110 pledged of $50K (80%)
  • 389 backers
  • 56 days to go